Fiasp

Active Ingredient(s): Insulin Aspart
FDA Approved: * September 29, 2017
Pharm Company: * NOVO NORDISK INC
Category: Diabetes

Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a type of manufactured insulin used to treat type 1 and type 2 diabetes.[12] It is generally used by injection under the skin but may also be used by injection into a vein.[12] Maximum effect occurs after about 1–3 hours and lasts for 3–5 hours.[12] Generally a longer-acting insulin like insulin NPH is also needed.[12] Common side effects in... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Fiasp 100 [Iu]/Ml Subcutaneous Injection, Solution
NDC: 0169-3201
Labeler:
Novo Nordisk
Fiasp 100 [Iu]/Ml Subcutaneous Injection, Solution
NDC: 0169-3204
Labeler:
Novo Nordisk
Fiasp 100 [Iu]/Ml Subcutaneous Injection, Solution
NDC: 0169-3205
Labeler:
Novo Nordisk
Fiasp 100 [Iu]/Ml Subcutaneous Injection, Solution
NDC: 0169-3206
Labeler:
Novo Nordisk